Publicaties
Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke Vrije Universiteit Brussel Universiteit Antwerpen
Methods: In a cohort of 169 patients, 60 patients (35.5%) received IV rtPA according to the European license criteria. The remaining patients received off-label IV rtPA and/or were treated with ...
Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19 Vrije Universiteit Brussel KU Leuven
BACKGROUND AND OBJECTIVES: COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.
METHODS: This was a retrospective multicenter cohort study of consecutive patients with AIS ...
Carboxypeptidase U (CPU, TAFIa, CPB2) in thromboembolic disease Universiteit Antwerpen
Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis Vrije Universiteit Brussel Universiteit Gent
Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hemorrhagic origin. Thrombolysis within 4.5 h of ischemic stroke onset improves outcome. Guidelines recommend administration of intravenous recombinant tissue plasminogen activator within 60 min upon arrival at the hospital, meaning the door-to-needle time (DNT) should be less than 60 min. In this study, a stroke protocol was introduced at the ...